CP and COVID-19: These studies indicate that despite the existence of anti-virals and other drugs found in the market and proposed to have ameliorative action against COVID-19, the understanding and use of antibodies (CP) could be a more effective solution in cases where the patient does not have time for the anti-virals to take effect.